Aticef-T 1.125 Injection
Marketer
Algen Healthcare Limited
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Aticef-T 1.125 Injection
Ceftibuten 1.125 mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial proliferation, thus curbing infection spread. Administration must be solely under medical guidance. Complete the prescribed treatment regimen; premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms to your physician promptly. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before initiating treatment, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor might order tests to monitor treatment response.
Primary Ingredients of Aticef-T 1.125 Injection
No information provided. Unable to rephrase.
Uses of Aticef-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Aticef-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Aticef-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Aticef-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Aticef-T 1.125 Injection works:
Aticef-T 1.125 Injection merges Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Aticef-T 1.125 Injection's concurrent use with alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Ceftazidime/Tazobactam 1.125 g injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
The administration of Aticef-T 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Ceftazidime/Tazobactam injection (1.125g) can induce drowsiness, blurred vision, and dizziness. Refrain from driving if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Aticef-T 1.125 Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Ceftizoxime 1.125 gram injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for this injection is generally unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Aticef-T 1.125 Injection :
Should you forget a dose of Aticef-T 1.125 Injection, seek your physician's advice.
Facts to Know About Aticef-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently